GLPwatch
Papers (9189)
Page 147 of 154, ranked by citation count.
- Tirzepatide improves angiogenesis after diabetic hindlimb ischemia through Akt/eNOS and ERK1/2 pathways.
- [Prescribing semaglutide for overweight: is it allowed?]
- Comparative Effectiveness of Tirzepatide Versus Dulaglutide or Semaglutide on Major Cardiovascular Events in Type 2 Diabetes and Cardiovascular Disease: Insights From Two Target-Trial Emulations.
- Comparative Analysis of Efficacy and Safety of the Glucagon-Like-Peptide-1 Receptor Agonists Tirzepatide and Semaglutide in Solid-Organ Transplant Recipients.
- Compounded Tirzepatide Therapy for Weight Loss: A Health Economics & Outcomes Research (HEOR) Analysis.
- GLP-1 agonists in glycemic and weight control of type 2 diabetes. New perspectives.
- Comparative efficacy of tirzepatide and glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes: a systematic review and network meta-analysis.
- [Effect and mechanism of liraglutide on the apoptosis of human hepatocellular carcinoma HepG2 cells induced with palmitic acid].
- Genetic predictors of GLP1 receptor agonist weight loss and side effects.
- Liraglutide as a novel therapeutic for overweight in canines: A clinical study.
- [Cardiovascular and renal protection of patients with type 2 diabetes : focus after EMPA-REG OUTCOME and LEADER].
- Does evidence matter? Comparative effectiveness research and prescribing of Type 2 diabetes mellitus drugs.
- [Victoza changes diabetes and lives of patients 5 years already].
- Efficacy of tirzepatide in glycemic control and weight management in adults with type 2 diabetes: a systematic review and meta-analysis of real-world studies.
- Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults.
- GLP-1 receptor agonists and sexual function in women and men: a narrative review of emerging evidence and the need for further research.
- Semaglutide Reduces Cardiomyocyte Damage Caused by High-Fat Through HSDL2.
- Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined. Reply.
- Impact of glucagon-like peptide-1 receptor agonism-based therapies on limb outcomes in peripheral artery disease and type 2 diabetes: An updated systematic review and meta-analysis.
- A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Efficacy and Adverse Events.
- Tirzepatide-induced ketoacidosis with hyperglycemia in a patient without diabetes.
- Improvement of Chronic Spontaneous Urticaria After Glucagon-Like Peptide 1 Receptor Agonist Therapy: Report of Two Cases.
- Depressed mood and suicidal thoughts reporting with GLP-1 receptor agonists in type 2 diabetes: A WHO VigiBase study.
- [SURMOUNT-OSA study : tirzepatide improves obstructive sleep apnoea in patients with obesity].
- Effect of liraglutide on subclinical atherosclerosis and cardiometabolic risk factors in adults with type 1 diabetes: A prospective pilot study.
- [Twice-daily and weekly exenatide: clinical profile of two pioneer formulations in incretin therapy].
- Therapeutic efficacy of synthetic analogues of gut hormones in a mouse model of Alzheimer's disease.
- Characterization of Interchanging Incretin Analogs in Clinical Practice: A Descriptive Report.
- Retrospective Analysis of Hospitalized Patients with Type 2 Diabetes Mellitus Treated with Glucagon-Like Peptide 1 Receptor Agonist Therapy.
- Severe diabetic ketoacidosis associated with insulin dose reduction after tirzepatide initiation.
- MicroRNA-451a downregulation in liraglutide-treated individuals with diabetes: A potential cardiovascular protective mechanism.
- [New hypoglycemic agents in type 2 diabetes].
- Effect of glucagon-like peptide-1 receptor agonists on heart rate in non-diabetic individuals with overweight or obesity: a systematic review and pairwise and network meta-analysis of randomized controlled trials.
- Tirzepatide improves extracellular matrix integrity and vascularization in pancreatic islets of a mouse model of obesity, diabetes, and menopause.
- A commentary on 'Boosting weight loss after conversional Roux-en-Y Gastric Bypass with liraglutide and placebo use. A double-blind-randomized controlled trial'.
- Tirzepatide in solid organ transplant recipients: Early real-world signals of efficacy and safety-A narrative review.
- Comparative effectiveness of continuous positive airway pressure and glucagon-like peptide-1 receptor agonists in obstructive sleep apnea: A network meta-analysis of randomised trials.
- [SURPASS CVOT : cardiovascular benefits with tirzepatide versus dulaglutide in type 2 diabetes].
- Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimens.
- Liraglutide for type 2 diabetes?
- [Towards evidence-based medicine: large-scale intervention trials with glucagon-like peptide-1 receptor agonists].
- Is Weight Loss the Main Driver for A1C Improvement by Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists? A 2.5-Year Analysis in Real-World Clinical Practice.
- [Liraglutide in the treatment of obesity : a multidisciplinary approach].
- Characterization of tirzepatide-treated patients achieving different glycemic control levels in SURPASS-AP-Combo.
- Once-weekly exenatide as a treatment for Type 2 diabetes.
- [Nutritional management of type 2 diabetes with GLP-1 and GLP-1/GIP agonists].
- Analysis of the Efficacy of Polyenyl Phosphatidylcholine in Combination with Liraglutide in Nonalcoholic Fatty Liver Disease and the Effect of Omentin-1 and Vaspin Expression.
- A real-world study of tirzepatide for weight loss in adults without diabetes mellitus.
- Low discontinuation rate of tirzepatide treatment in Japanese patients with diabetes mellitus; importance of traditional Japanese diet.
- Is it time to reassess the role of myocardial metabolic modulation for the treatment of heart failure?
- Emulating the LEADER trial in China: a regulatory science case study on non-interventional research.
- Liraglutide reduces the apoptosis of feeding and appetite-suppressing neurons in the hypothalamus of obese rats association with the PI3K/AKT/Foxo1 pathway.
- Are Glucagon-Like Peptide 1 Receptor Agonists and Bariatric Surgery the Answer to Childhood Obesity?
- Digital Engagement Significantly Enhances Weight Loss Outcomes in Adults With Obesity Treated With Tirzepatide: Retrospective Cohort Study of a Digital Weight Loss Service.
- Efficacy and safety of once-weekly semaglutide monotherapy in a young subject with Prader-Willi syndrome, obesity, and type 2 diabetes: a case report.
- Tirzepatide-Associated Euglycemic Diabetic Ketoacidosis in the Absence of Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report.
- [Effects of GLP-1 receptor agonists on carbohydrate metabolism control].
- Tirzepatide as Adjunct to Insulin in Adults With Type 1 Diabetes and Overweight or Obesity: A Systematic Review of Randomized and Real-World Evidence.
- Effect of Weight-Neutral Treatment With Semaglutide or Tirzepatide on β-Cell Identity in db/db Mice.
- HIPPOCAMPAL GANGLIOSIDE COMPOSITION IS ALTERED BY METFORMIN AND LIRAGLUTIDE TREATMENT IN A HIGH-FAT HIGH-SUGAR DIET RAT MODEL.